Back

Hyperkalaemia and iron deficiency in chronic heart failure – how important?

25 August 2018 (15:30 - 15:45)
Organised by:
Congress Presentation Part of: Co-morbidities in chronic heart failure – time for paradigm shifts in the management of hyperkalaemia and iron deficiency Chronic Heart Failure Open Access ESC Congress 2018

About the speaker

Photo
Professor Stefan Anker

Charite University Hospital, Berlin (Germany)

3 More presentations in this session

Presentation thumbnail
Advances in hyperkalaemia management – overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.
Professor I. Pina (Philadelphia, US)
Slides Video
Presentation thumbnail
Iron deficiency management – impact on clinically important outcomes.
Professor P. Van Der Meer (Groningen, NL)
Slides Video
Presentation thumbnail
Panel discussion and close - Hyperkalaemia and iron deficiency: time for a paradigm change.
Professor I. Pina (Philadelphia, US) Professor G. Filippatos (Athens, GR) Professor J. Butler (Dallas, US) Professor S. Anker (Berlin, DE) Professor P. Van Der Meer (Groningen, NL)
Slides Video

Access the full session

Session thumbnail
Co-morbidities in chronic heart failure – time for paradigm shifts in the management of hyperkalaemia and iron deficiency

The Event

Event poster

ESC Congress 2018

25 August 2018 15:30 CET
You may be interested in
thumbnail
Congress Session
Treatment of iron deficiency in heart failure: new evidence and practical guidance
18 May 2025
thumbnail
Webinar
How to optimise RAASi therapy in patients with hyperkalaemia
15 December 2021
thumbnail
Congress Presentation
Hypophosphatemia in HFrEF patients after intravenous iron supplementation
21 May 2023
thumbnail
Congress Session
Comorbidities
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources